Dhanuka Agritech’s Q3 FY25 Net Profit up 21.3% YoY to Rs 55.04 Cr

Company’s revenue from operations grows 10.4 per cent Y-O-Y to Rs 445.27 Crore in Q3 FY25 and EBITDA improves 21.6 per cent Y-O-Y to Rs. 75.56 Crore.

Dhanuka Agritech Limited, one of India’s leading crop protection companies listed on BSE and NSE, has announced financial results for the third quarter of the 2024-25 fiscal year, reporting strong growth across key performance indicators, Dhanuka Agritech remains on track with its goals and initiatives.

Gurugram-headquartered firm clocked Rs. 55.04 crore profit during October-December quarter 3 of FY’25, up 21.3 per cent from the same quarter of the previous fiscal year.

Management’s Perspective on Q3FY25 Performance

Reflecting on the company’s second-quarter performance, Mahendra Kumar Dhanuka, Chairman of Dhanuka Agritech, stated, “Our Q3 performance reflects strong demand and strategic planning, supported by efficient distribution and farmer’s support. The progress we’ve made is a result of our focus on innovation, operational efficiency, and our commitment to integrity and environmental responsibility. We’ll continue pushing for even greater success in the future.”

Dhanuka added, “This season has been highly promising, with substantial acreage in key crops, as anticipated. A favorable winter season has further strengthened demand, setting a positive trajectory. Looking ahead, we are well-positioned to continue our growth and enhance our product offerings, all while delivering exceptional value to our distribution network and customers”.

Highlights:

Dhanuka Agritech has successfully concluded its INR 165 crore strategic acquisition deal for international rights to foray into global markets and distribution of its two prominent fungicides, Iprovalicarb and Triadinenol from Bayer AG.

Financial Performance Update

Company’s revenue from operations grows 10.4 per